Reply to 'Re: Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'.
Bart GeboersMatthijs J V ScheltemaLouise EmmettPhillip D StrickerPublished in: BJU international (2024)
Keyphrases
- prostate cancer
- positron emission tomography
- computed tomography
- magnetic resonance imaging
- end stage renal disease
- radical prostatectomy
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- pet ct
- pet imaging
- stem cells
- contrast enhanced
- patient reported
- replacement therapy
- smoking cessation